Colgate-Palmolive (NYSE:CL) Position Raised by Wedmont Private Capital

Wedmont Private Capital raised its position in shares of Colgate-Palmolive (NYSE:CL) by 53.1% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 12,391 shares of the company’s stock after purchasing an additional 4,295 shares during the quarter. Wedmont Private Capital’s holdings in Colgate-Palmolive were worth $1,070,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Reston Wealth Management LLC bought a new position in Colgate-Palmolive during the third quarter valued at about $42,000. Capital Performance Advisors LLP acquired a new stake in Colgate-Palmolive in the 3rd quarter valued at about $53,000. Prospera Private Wealth LLC bought a new position in shares of Colgate-Palmolive during the 3rd quarter valued at about $64,000. True Wealth Design LLC grew its stake in shares of Colgate-Palmolive by 1,460.9% in the 3rd quarter. True Wealth Design LLC now owns 718 shares of the company’s stock worth $75,000 after purchasing an additional 672 shares during the last quarter. Finally, Continuum Advisory LLC raised its holdings in shares of Colgate-Palmolive by 93.4% in the 3rd quarter. Continuum Advisory LLC now owns 762 shares of the company’s stock worth $79,000 after purchasing an additional 368 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Up 0.8 %

Colgate-Palmolive stock opened at $87.02 on Tuesday. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a 1-year low of $79.69 and a 1-year high of $109.30. The firm’s fifty day simple moving average is $92.49 and its 200-day simple moving average is $97.98. The company has a market capitalization of $71.10 billion, a P/E ratio of 24.93, a P/E/G ratio of 3.31 and a beta of 0.44.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 21st will be given a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.30%. Colgate-Palmolive’s dividend payout ratio is currently 57.31%.

Analyst Upgrades and Downgrades

CL has been the subject of a number of research reports. Stifel Nicolaus cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and reduced their target price for the stock from $105.00 to $101.00 in a report on Monday, October 28th. Wells Fargo & Company decreased their target price on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a report on Tuesday, January 7th. StockNews.com downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. JPMorgan Chase & Co. lifted their price target on Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Finally, TD Cowen reduced their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research note on Wednesday, January 8th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have issued a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $103.63.

Insider Activity

In related news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 0.34% of the stock is currently owned by insiders.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.